209 results on '"Petracci, Barbara"'
Search Results
2. Comparing SRI funds to conventional funds using a PCA methodology
3. Does corporate social responsibility impact equity risk? International evidence
4. Precautionary motives for private firms’ cash holdings
5. ICD-measured heart sounds and their correlation with echocardiographic indexes of systolic and diastolic function
6. Is the market surprised by the surprise?
7. Incidence of appropriate anti-tachycardia therapies after elective generator replacement in patient with heart failure initially implanted with a defibrillator for primary prevention: Results of a meta-analysis
8. Corporate Social Responsibility and Cost of Financing -the importance of the International Corporate Governance system
9. Can board gender diversity promote corporate social performance?
10. QTc Interval and Mortality in a Population of SARS-2-CoV Infected Patients
11. Developing the Islamic Financial Services Sector in Italy: An Institutional Theory Perspective
12. Submammary device implantation. Good long-term performance and better patients' satisfaction. A single-center experience
13. LA FINANZA ETICA : UN APPROCCIO POSSIBILE?
14. Does gender diverse board mean less earnings management?
15. Bibliometric Analysis and Systematic Literature Review on Social Impact Bonds
16. Investors' reaction under uncertainty.
17. Egregious separation payments? The role of internal and external corporate governance
18. Failure of implantable cardioverter-defibrillator leads: A matter of lead size?
19. Cost of entrepreneurial capital and under-diversification: A Euro-Mediterranean perspective
20. Abstract 20851: Incidence of Appropriate ICD Therapies After Elective Generator Replacement in Patient With Heart Failure Initially Implanted for Primary Prevention: A Systematic Literature Review and Metanalysis
21. “Hit and Run” and “Revolving Doors”: evidence from the Italian stock market
22. Investors’ reaction under uncertainty
23. Decongestive treatment adjustments in heart failure patients remotely monitored with a multiparametric implantable defibrillators algorithm
24. PO-662-07 DECONGESTIVE TREATMENT ADJUSTMENTS IN HEART FAILURE PATIENTS REMOTELY MONITORED WITH A MULTIPARAMETRIC ICD ALGORITHM
25. The Determinants of Regulatory Compliance: An Analysis of Insider Trading Disclosures in Italy
26. Do what insiders do : Abnormal performances after the release of insiders' relevant transactions
27. Trading when you cannot trade: Blackout periods in Italian firms
28. Economic Sustainability, Innovation, and the ESG Factors: An Empirical Investigation
29. Investors’ reaction under uncertainty
30. Egregious separation payments The role of internal and external corporate governance
31. Stakeholder engagement: Investors' environmental risk aversion and corporate earnings
32. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer
33. Anatomical Mapping for Atrial Fibrillation Ablation: A Head-to-Head Comparison of Ultrasound-Assisted Reconstruction versus Fast Anatomical Mapping
34. Long-term outcome of catheter ablation for atrial fibrillation in patients with severe left atrial enlargement and reduced left ventricular ejection fraction
35. Incidence of Ventricular Arrhythmias and 1‐Year Predictors of Mortality in Patients Treated With Implantable Cardioverter‐Defibrillator Undergoing Generator Replacement
36. Delayed ICD Lead Cardiac Perforation: Comparison of Small versus Standard-Diameter Leads Implanted in a Single Center
37. Prospective evaluation of the multisensor HeartLogic algorithm for heart failure monitoring
38. Corporate social responsibility and cost of financing—The importance of the international corporate governance system
39. Relevance of Echocardiographic Evaluation of Right Ventricular Function in Patients Undergoing Cardiac Resynchronization Therapy
40. Intermittent rate-dependent retrograde conduction over a concealed atrioventricular accessory pathway: what is the mechanism?
41. Stakeholder engagement: Investors' environmental risk aversion and corporate earnings.
42. Left Ventricular Pacing Lead Positioning in the Target Vein of the Coronary Sinus: Description of a Challenging Case
43. Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator
44. Separation Payments and Corporate Governance: An Ethical Perspective
45. The Role of the Institutional Framework in the Relationship between Earnings Management and Corporate Social Performance
46. Preliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring: a retrospective case series report
47. Autosomal recessive atrial disease presenting with sick sinus syndrome (SSS), right atrial fibrosis and biatrial dilatation: Clinical impact of genetic diagnosis
48. Percutaneous left stellate ganglion block in patients with electrical storm. Our preliminary results
49. La finanza etica: un approccio possibile?
50. Does Corporate Social Responsibility Impact Risk?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.